Jeri Williams Sells 307 Shares of Axon Enterprise, Inc. (NASDAQ:AXON) Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Jeri Williams sold 307 shares of the company’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Axon Enterprise Stock Up 5.2 %

Shares of NASDAQ:AXON opened at $568.11 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $592.48 and a two-hundred day simple moving average of $539.47. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99. The stock has a market capitalization of $43.53 billion, a price-to-earnings ratio of 146.80, a PEG ratio of 5.17 and a beta of 1.12.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently modified their holdings of the stock. Fourth Dimension Wealth LLC purchased a new stake in Axon Enterprise during the 4th quarter valued at about $30,000. Prestige Wealth Management Group LLC lifted its stake in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $40,000. Brooklyn Investment Group bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $41,000. Finally, Y.D. More Investments Ltd bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $45,000. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on AXON shares. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 26th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.